Questions About Cancer? 1-800-4-CANCER

NCI Shady Grove Now Open

  • Updated: 03/22/2013

NCI’s new location, NCI Shady Grove, is open at 9609 Medical Center Drive in Rockville, MD. While NCI's clinical program remains on the NIH campus in Bethesda, NCI Shady Grove will accommodate approximately 2,450 administrative and program staff who previously occupied Executive Plaza and Helgerman Court buildings in Rockville. Offices at NCI started moving into the new building in December 2012 and the move will be completed within six months. The new location features two office towers with a connector wing on the lower floors and has 574,000 net square feet of usable space.

"By consolidating staff from four locations into the new NCI Shady Grove location and through a competitive bidding process, we expect to save 10 percent or more in our lease and utility costs," noted Daryl Paunil, P.E., Director, NCI Office of Space and Facilities Management. "This new facility has been designed to allow for easier renovations and new configurations to foster more scientific collaboration amongst NCI staff."

"We are pleased to announce that the buildings are LEED Gold (Leadership in Energy and Environmental Design) certified which means that NCI employees will be working in some of the most environmentally-friendly workspaces in the Washington metropolitan area," explained Paunil. "For example, the building features a green roof, outdoor green space and a daylight harvesting system that allows NCI to maximize the usage of natural light and reduce energy costs."

NCI Shady Grove is conveniently accessible from several exits off Interstate 270 and is located about six miles north of the Executive Plaza location. In addition, NCI Shady Grove has Metrobus and Ride-On stops near the buildings. The nearby Shady Grove Metrorail station will be serviced by Ride-On bus. Shuttle service will also be available from NCI Shady Grove to the NIH campus in Bethesda.

The General Services Administration (GSA) determined the new NCI Shady Grove location in close consultation with NIH and NCI. The selections were based on a rigorous, year-long competitive bidding process conducted by GSA.